These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 8161475

  • 1. [The role of endothelin in the progression of the renal disease in an experimental model of chronic kidney failure].
    Orisio S, Zoja C, Remuzzi G.
    Ann Ital Med Int; 1993; 8(4):213-7. PubMed ID: 8161475
    [Abstract] [Full Text] [Related]

  • 2. Nitric oxide/endothelin balance after nephron reduction.
    Aiello S, Remuzzi G, Noris M.
    Kidney Int Suppl; 1998 Apr; 65():S63-7. PubMed ID: 9551434
    [Abstract] [Full Text] [Related]

  • 3. Glomerular macrophage modulation affects mesangial expansion in the rat after renal ablation.
    van Goor H, van der Horst ML, Fidler V, Grond J.
    Lab Invest; 1992 May; 66(5):564-71. PubMed ID: 1573851
    [Abstract] [Full Text] [Related]

  • 4. Influence of dietary protein/calorie intake on renal morphology and function in cats with 5/6 nephrectomy.
    Adams LG, Polzin DJ, Osborne CA, O'Brien TD, Hostetter TH.
    Lab Invest; 1994 Mar; 70(3):347-57. PubMed ID: 8145529
    [Abstract] [Full Text] [Related]

  • 5. Time course and localization of endothelin-1 gene expression in a model of renal disease progression.
    Bruzzi I, Corna D, Zoja C, Orisio S, Schiffrin EL, Cavallotti D, Remuzzi G, Benigni A.
    Am J Pathol; 1997 Nov; 151(5):1241-7. PubMed ID: 9358749
    [Abstract] [Full Text] [Related]

  • 6. Role of endothelin and endothelin receptor antagonists in renal disease.
    Neuhofer W, Pittrow D.
    Eur J Clin Invest; 2006 Sep; 36 Suppl 3():78-88. PubMed ID: 16919017
    [Abstract] [Full Text] [Related]

  • 7. Endothelin: a mediator of renal disease progression.
    Bruzzi I, Remuzzi G, Benigni A.
    J Nephrol; 1997 Sep; 10(4):179-83. PubMed ID: 9377723
    [Abstract] [Full Text] [Related]

  • 8. [Molecular mechanisms of nephro-protective action of enalapril in experimental chronic renal failure].
    Ciechanowicz A.
    Ann Acad Med Stetin; 1999 Sep; Suppl 52():1-93. PubMed ID: 10589103
    [Abstract] [Full Text] [Related]

  • 9. Renal endothelin gene expression is increased in remnant kidney and correlates with disease progression.
    Orisio S, Benigni A, Bruzzi I, Corna D, Perico N, Zoja C, Benatti L, Remuzzi G.
    Kidney Int; 1993 Feb; 43(2):354-8. PubMed ID: 8441230
    [Abstract] [Full Text] [Related]

  • 10. Endothelin in the progressive renal disease of glomerulopathies.
    Benigni A, Remuzzi G.
    Miner Electrolyte Metab; 1995 Feb; 21(4-5):283-91. PubMed ID: 7565477
    [Abstract] [Full Text] [Related]

  • 11. Passive Heymann nephritis: evidence that angiotensin-converting enzyme inhibition reduces proteinuria and retards renal structural injury.
    Zoja C, Corna D, Bruzzi I, Foglieni C, Bertani T, Remuzzi G, Benigni A.
    Exp Nephrol; 1996 Feb; 4(4):213-21. PubMed ID: 8983642
    [Abstract] [Full Text] [Related]

  • 12. The mTOR inhibitor everolimus induces proteinuria and renal deterioration in the remnant kidney model in the rat.
    Vogelbacher R, Wittmann S, Braun A, Daniel C, Hugo C.
    Transplantation; 2007 Dec 15; 84(11):1492-9. PubMed ID: 18091526
    [Abstract] [Full Text] [Related]

  • 13. Role of the extracellular matrix in the development of glomerulosclerosis in experimental chronic serum sickness.
    Bergijk EC, Baelde HJ, de Heer E, Killen PD, Bruijn JA.
    Exp Nephrol; 1995 Dec 15; 3(6):338-47. PubMed ID: 8528678
    [Abstract] [Full Text] [Related]

  • 14. Endothelin-1 in chronic renal failure and hypertension.
    Larivière R, Lebel M.
    Can J Physiol Pharmacol; 2003 Jun 15; 81(6):607-21. PubMed ID: 12839272
    [Abstract] [Full Text] [Related]

  • 15. Reversal of proteinuric renal disease and the emerging role of endothelin.
    Barton M.
    Nat Clin Pract Nephrol; 2008 Sep 15; 4(9):490-501. PubMed ID: 18648345
    [Abstract] [Full Text] [Related]

  • 16. Role of endothelin ETB receptor in partial ablation-induced chronic renal failure in rats.
    Okada Y, Nakata M, Izumoto H, Takasu M, Tazawa N, Takaoka M, Gariepy CE, Yanagisawa M, Matsumura Y.
    Eur J Pharmacol; 2004 Jun 21; 494(1):63-71. PubMed ID: 15194452
    [Abstract] [Full Text] [Related]

  • 17. Role of endothelin in cardiovascular disease.
    Agapitov AV, Haynes WG.
    J Renin Angiotensin Aldosterone Syst; 2002 Mar 21; 3(1):1-15. PubMed ID: 11984741
    [Abstract] [Full Text] [Related]

  • 18. [The role of tubulointerstitial changes in progression of kidney function failure in patients with chronic glomerulonephritis (GN)].
    Idasiak-Piechocka I, Krzymański M.
    Przegl Lek; 1996 Mar 21; 53(5):443-53. PubMed ID: 8754411
    [Abstract] [Full Text] [Related]

  • 19. A re-evaluation of the renal ablation model of progressive renal disease in rats.
    Kim KH, Kim Y, Park HW, Jeong HJ, Mauer M.
    J Nephrol; 2003 Mar 21; 16(2):196-202. PubMed ID: 12768066
    [Abstract] [Full Text] [Related]

  • 20. Endothelin is a key modulator of progressive renal injury: experimental data and novel therapeutic strategies.
    Bruzzi I, Benigni A.
    Clin Exp Pharmacol Physiol; 1996 Apr 21; 23(4):349-53. PubMed ID: 8717073
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.